Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; microcrystalline cellulose; iron oxide yellow; sodium starch glycollate type a; sodium lauryl sulfate; lactose monohydrate - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; iron oxide red; sodium starch glycollate type a; povidone; sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; povidone; indigo carmine aluminium lake - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium starch glycollate type a; povidone; sodium lauryl sulfate; microcrystalline cellulose; indigo carmine aluminium lake - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; sodium lauryl sulfate; sodium starch glycollate type a; magnesium stearate; iron oxide yellow; microcrystalline cellulose - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium lauryl sulfate; sodium starch glycollate type a; povidone; microcrystalline cellulose; iron oxide yellow; indigo carmine aluminium lake - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; sodium lauryl sulfate; sodium starch glycollate type a; microcrystalline cellulose; iron oxide yellow; indigo carmine aluminium lake - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; iron oxide red; povidone; sodium lauryl sulfate; sodium starch glycollate type a; magnesium stearate - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: iron oxide red; sodium starch glycollate type a; sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose; lactose monohydrate; povidone - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - flecainide acetate, quantity: 50 mg - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; maize starch; silicified microcrystalline cellulose - flecain is indicated for:,1. supraventricular arrhythmias:,a) due to pre-excitation syndromes, e.g. wolff-parkinson-white and lown-ganong-levine syndromes,b) due to dual av nodal pathways in patients with debilitating symptoms,c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms,although flecainide acetate may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life-threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, flecain should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate.,use of flecainide acetate in chronic atrial fibrillation has not been adequately studied and is not recommended.,2. life threatening ventricular arrhythmias not controlled by other drugs.,flecain tablets are used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means.,prescribers should also consult the "precautions" section of this product information.